1 Market Overview

• 1.1 Product Overview and Scope of Parecoxib Sodium
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Parecoxib Sodium Consumption Value by Type: 2019 Versus 2023 Versus 2030
  • 1.3.2 Original Drug
  • 1.3.3 Generic Drug
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Parecoxib Sodium Consumption Value by Application: 2019 Versus 2023 Versus 2030
  • 1.4.2 Hospital Pharmacies
  • 1.4.3 Retail Pharmacies
  • 1.4.4 Online Pharmacies
• 1.5 Global Parecoxib Sodium Market Size & Forecast
  • 1.5.1 Global Parecoxib Sodium Consumption Value (2019 & 2023 & 2030)
  • 1.5.2 Global Parecoxib Sodium Sales Quantity (2019-2030)
  • 1.5.3 Global Parecoxib Sodium Average Price (2019-2030)

2 Manufacturers Profiles

• 2.1 Pfizer
  • 2.1.1 Pfizer Details
  • 2.1.2 Pfizer Major Business
  • 2.1.3 Pfizer Parecoxib Sodium Product and Services
  • 2.1.4 Pfizer Parecoxib Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.1.5 Pfizer Recent Developments/Updates
• 2.2 Sailong Pharma
  • 2.2.1 Sailong Pharma Details
  • 2.2.2 Sailong Pharma Major Business
  • 2.2.3 Sailong Pharma Parecoxib Sodium Product and Services
  • 2.2.4 Sailong Pharma Parecoxib Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.2.5 Sailong Pharma Recent Developments/Updates
• 2.3 Chiarai Tianqing
  • 2.3.1 Chiarai Tianqing Details
  • 2.3.2 Chiarai Tianqing Major Business
  • 2.3.3 Chiarai Tianqing Parecoxib Sodium Product and Services
  • 2.3.4 Chiarai Tianqing Parecoxib Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.3.5 Chiarai Tianqing Recent Developments/Updates
• 2.4 Qilu Pharma
  • 2.4.1 Qilu Pharma Details
  • 2.4.2 Qilu Pharma Major Business
  • 2.4.3 Qilu Pharma Parecoxib Sodium Product and Services
  • 2.4.4 Qilu Pharma Parecoxib Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.4.5 Qilu Pharma Recent Developments/Updates
• 2.5 Kelun Pharma
  • 2.5.1 Kelun Pharma Details
  • 2.5.2 Kelun Pharma Major Business
  • 2.5.3 Kelun Pharma Parecoxib Sodium Product and Services
  • 2.5.4 Kelun Pharma Parecoxib Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.5.5 Kelun Pharma Recent Developments/Updates

3 Competitive Environment: Parecoxib Sodium by Manufacturer

• 3.1 Global Parecoxib Sodium Sales Quantity by Manufacturer (2019-2024)
• 3.2 Global Parecoxib Sodium Revenue by Manufacturer (2019-2024)
• 3.3 Global Parecoxib Sodium Average Price by Manufacturer (2019-2024)
• 3.4 Market Share Analysis (2023)
  • 3.4.1 Producer Shipments of Parecoxib Sodium by Manufacturer Revenue ($MM) and Market Share (%): 2023
  • 3.4.2 Top 3 Parecoxib Sodium Manufacturer Market Share in 2023
  • 3.4.2 Top 6 Parecoxib Sodium Manufacturer Market Share in 2023
• 3.5 Parecoxib Sodium Market: Overall Company Footprint Analysis
  • 3.5.1 Parecoxib Sodium Market: Region Footprint
  • 3.5.2 Parecoxib Sodium Market: Company Product Type Footprint
  • 3.5.3 Parecoxib Sodium Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Parecoxib Sodium Market Size by Region
  • 4.1.1 Global Parecoxib Sodium Sales Quantity by Region (2019-2030)
  • 4.1.2 Global Parecoxib Sodium Consumption Value by Region (2019-2030)
  • 4.1.3 Global Parecoxib Sodium Average Price by Region (2019-2030)
• 4.2 North America Parecoxib Sodium Consumption Value (2019-2030)
• 4.3 Europe Parecoxib Sodium Consumption Value (2019-2030)
• 4.4 Asia-Pacific Parecoxib Sodium Consumption Value (2019-2030)
• 4.5 South America Parecoxib Sodium Consumption Value (2019-2030)
• 4.6 Middle East and Africa Parecoxib Sodium Consumption Value (2019-2030)

5 Market Segment by Type

• 5.1 Global Parecoxib Sodium Sales Quantity by Type (2019-2030)
• 5.2 Global Parecoxib Sodium Consumption Value by Type (2019-2030)
• 5.3 Global Parecoxib Sodium Average Price by Type (2019-2030)

6 Market Segment by Application

• 6.1 Global Parecoxib Sodium Sales Quantity by Application (2019-2030)
• 6.2 Global Parecoxib Sodium Consumption Value by Application (2019-2030)
• 6.3 Global Parecoxib Sodium Average Price by Application (2019-2030)

7 North America

• 7.1 North America Parecoxib Sodium Sales Quantity by Type (2019-2030)
• 7.2 North America Parecoxib Sodium Sales Quantity by Application (2019-2030)
• 7.3 North America Parecoxib Sodium Market Size by Country
  • 7.3.1 North America Parecoxib Sodium Sales Quantity by Country (2019-2030)
  • 7.3.2 North America Parecoxib Sodium Consumption Value by Country (2019-2030)
  • 7.3.3 United States Market Size and Forecast (2019-2030)
  • 7.3.4 Canada Market Size and Forecast (2019-2030)
  • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

• 8.1 Europe Parecoxib Sodium Sales Quantity by Type (2019-2030)
• 8.2 Europe Parecoxib Sodium Sales Quantity by Application (2019-2030)
• 8.3 Europe Parecoxib Sodium Market Size by Country
  • 8.3.1 Europe Parecoxib Sodium Sales Quantity by Country (2019-2030)
  • 8.3.2 Europe Parecoxib Sodium Consumption Value by Country (2019-2030)
  • 8.3.3 Germany Market Size and Forecast (2019-2030)
  • 8.3.4 France Market Size and Forecast (2019-2030)
  • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  • 8.3.6 Russia Market Size and Forecast (2019-2030)
  • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

• 9.1 Asia-Pacific Parecoxib Sodium Sales Quantity by Type (2019-2030)
• 9.2 Asia-Pacific Parecoxib Sodium Sales Quantity by Application (2019-2030)
• 9.3 Asia-Pacific Parecoxib Sodium Market Size by Region
  • 9.3.1 Asia-Pacific Parecoxib Sodium Sales Quantity by Region (2019-2030)
  • 9.3.2 Asia-Pacific Parecoxib Sodium Consumption Value by Region (2019-2030)
  • 9.3.3 China Market Size and Forecast (2019-2030)
  • 9.3.4 Japan Market Size and Forecast (2019-2030)
  • 9.3.5 Korea Market Size and Forecast (2019-2030)
  • 9.3.6 India Market Size and Forecast (2019-2030)
  • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

• 10.1 South America Parecoxib Sodium Sales Quantity by Type (2019-2030)
• 10.2 South America Parecoxib Sodium Sales Quantity by Application (2019-2030)
• 10.3 South America Parecoxib Sodium Market Size by Country
  • 10.3.1 South America Parecoxib Sodium Sales Quantity by Country (2019-2030)
  • 10.3.2 South America Parecoxib Sodium Consumption Value by Country (2019-2030)
  • 10.3.3 Brazil Market Size and Forecast (2019-2030)
  • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

• 11.1 Middle East & Africa Parecoxib Sodium Sales Quantity by Type (2019-2030)
• 11.2 Middle East & Africa Parecoxib Sodium Sales Quantity by Application (2019-2030)
• 11.3 Middle East & Africa Parecoxib Sodium Market Size by Country
  • 11.3.1 Middle East & Africa Parecoxib Sodium Sales Quantity by Country (2019-2030)
  • 11.3.2 Middle East & Africa Parecoxib Sodium Consumption Value by Country (2019-2030)
  • 11.3.3 Turkey Market Size and Forecast (2019-2030)
  • 11.3.4 Egypt Market Size and Forecast (2019-2030)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

• 12.1 Parecoxib Sodium Market Drivers
• 12.2 Parecoxib Sodium Market Restraints
• 12.3 Parecoxib Sodium Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Parecoxib Sodium and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Parecoxib Sodium
• 13.3 Parecoxib Sodium Production Process
• 13.4 Parecoxib Sodium Industrial Chain

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Parecoxib Sodium Typical Distributors
• 14.3 Parecoxib Sodium Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Parecoxib Sodium market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Parecoxib Sodium (CAS 198470-85-8), C19H17N2NaO4S, the formula weight is 392.40, and its form is white solid.
Parecoxib sodium is used for short-term treatment of postoperative pain.
The Global Info Research report includes an overview of the development of the Parecoxib Sodium industry chain, the market status of Hospital Pharmacies (Original Drug, Generic Drug), Retail Pharmacies (Original Drug, Generic Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Parecoxib Sodium.
Regionally, the report analyzes the Parecoxib Sodium markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Parecoxib Sodium market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Parecoxib Sodium market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Parecoxib Sodium industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kg), revenue generated, and market share of different by Type (e.g., Original Drug, Generic Drug).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Parecoxib Sodium market.
Regional Analysis: The report involves examining the Parecoxib Sodium market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Parecoxib Sodium market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Parecoxib Sodium:
Company Analysis: Report covers individual Parecoxib Sodium manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Parecoxib Sodium This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Parecoxib Sodium. It assesses the current state, advancements, and potential future developments in Parecoxib Sodium areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Parecoxib Sodium market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Parecoxib Sodium market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Original Drug
Generic Drug
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major players covered
Pfizer
Sailong Pharma
Chiarai Tianqing
Qilu Pharma
Kelun Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Parecoxib Sodium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Parecoxib Sodium, with price, sales, revenue and global market share of Parecoxib Sodium from 2019 to 2024.
Chapter 3, the Parecoxib Sodium competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parecoxib Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Parecoxib Sodium market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Parecoxib Sodium.
Chapter 14 and 15, to describe Parecoxib Sodium sales channel, distributors, customers, research findings and conclusion.